The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Lung metastasis genes couple breast tumor size and metastatic spread
Open accessAbstract
The association between large tumor size and metastatic risk in a majority of clinical cancers has led to questions as to whether these observations are causally related or whether one is simply a marker for the other. This is partly due to an uncertainty about how metastasis-promoting gene expression changes can arise in primary tumors. We investigated this question through the analysis of a previously defined “lung metastasis gene-expression signature” (LMS) that mediates experimental breast cancer metastasis selectively to the lung and is expressed by primary human breast cancer with a high risk for developing lung metastasis. Experimentally, we demonstrate that the LMS promotes primary tumor growth that enriches for LMS + cells, and it allows for intravasation after reaching a critical tumor size. Clinically, this corresponds to LMS + tumors being larger at diagnosis compared with LMS − tumors and to a marked rise in the incidence of metastasis after LMS + tumors reach 2 cm. Patients with LMS-expressing primary tumors selectively fail in the lung compared with the bone or other visceral sites and have a worse overall survival. The mechanistic linkage between metastasis gene expression, accelerated tumor growth, and likelihood of metastatic recurrence provided by the LMS may help to explain observations of prognostic gene signatures in primary cancer and how tumor growth can both lead to metastasis and be a marker for cells destined to metastasize.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CXCL1 emerged among a set of genes whose expression is associated with lung relapse in breast tumors, including tumors that had not been exposed to prior chemotherapy (Minn et al., 2007; Minn et al., 2005), and as a gene that increases the aggressiveness of circulating breast tumor cells (Kim et al., 2009).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Minn et al., 2007
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature reviews. Cancer · doi:10.1038/nrc865 · Cited by 4,018
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Self-citation
Research works printed but not linked: 1
- H Ishwaran, UB Kogalur R News, in press. (2007).
Cited by
Sorted by citations
Items 301–400 of 400
Xia, R. M., Chen, S., Zhang, W., CHEN, Y., ZHU, R., & Deng, A. (2015) · Neoplasma · doi:10.4149/neo_2015_099 · Cited by 4
Daidone, M. G., Foekens, J. A., Harbeck, N., Martens, J. W. M., Brünner, N., Thomssen, C., Hall, J. A., Salgado, R., Dittmer, J., Geurts-Moespot, A. J., et al. (2012) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(12)70021-6 · Cited by 4
Self-citationSignificance of Studying Circulating Tumor Cells
Datar, R. H., Ao, Z., & Côté, R. J. (2016) · Current cancer research · doi:10.1007/978-1-4939-3363-1_1 · Cited by 4
A New Robust Method for Nonlinear Regression
Tabatabai, M. A., & Kengwoung-Keumo, J.-J. (2014) · Journal of Biometrics & Biostatistics · doi:10.4172/2155-6180.1000199 · Cited by 4
McDonald, E. S., Pan, T.-C., Pant, D. K., Troester, M. A., Kossenkov, A. V., Mankoff, D. A., Mach, R. H., & Chodosh, L. A. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0562 · Cited by 3
KLF8 promotes invasive outgrowth of breast cancer by inducing filopodium-like protrusions via CXCR4.
Mukherjee, D., Hao, J., Lu, H., Lahiri, S. K., Yu, L., & Zhao, J. (2022) · PubMed Central · Cited by 3
Identification of genes and pathways related to breast cancer metastasis in an integrated cohort
Wang, L., Mo, C., Wang, L., & Cheng, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13525 · Cited by 3
7.10 Cell-Extracellular Matrix Mechanobiology in Cancer
Kumar, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374920-8.00712-8 · Cited by 3
A high risk of osteosarcoma in individuals who are homozygous for the p.D104N in endostatin
Bi, W., Li, D.-W., Luo, S. J., Song, Z., Wang, Y., Jin, H., Wang, Y., Li, Q., Li, M., Wang, D., et al. (2015) · Scientific Reports · doi:10.1038/srep16392 · Cited by 3
Self-citationGrowth Regulatory Pathways Contributing to Organ Selectivity of Metastasis
Eccles, S. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976117.021 · Cited by 3
Wieland, V., & Hasenauer, J. (2025) · Journal of Mathematical Biology · doi:10.1007/s00285-025-02229-6 · Cited by 2
Singh, A. S., Bharadwaj, B. S., & Goswami, B. C. (2022) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2022.7.1.21-27 · Cited by 2
Sun, S., Man, X., Zhou, D., Zheng, F., Zhao, J., Chen, X., Liu, T., Huang, J., Tan, Q., Li, N., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6509 · Cited by 2
López‐Bonet, E., & Menéndez, J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp579 · Cited by 2
Annotated Compendium of 102 Breast Cancer Gene-Expression DatasetsPreprint
Nwosu, I. O., Tabler, D. D., Chipman, G., & Piccolo, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.22.559045 · Cited by 2
Prediction of Lung Metastasis in Breast Cancer Patients Using Machine Learning Classifiers
Nguyen, T. D., Nguyen, Q.-M. T., Nguyen, T. V., Bui, P. T., Nguyen, K. N. T., & Nguyen, M. N. (2025) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2025.10.010 · Cited by 1
Lu, J., Nia, R. S., Sun, J., Filippopoulou, C., Vega, D. D., Hu, P., Liang, H., Yao, H., Pan, C., Wu, X., et al. (2026) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1002/brv.70167 · Cited by 2
The molecular mechanisms of breast cancer metastasis
Ugenskienė, R., & Juozaitytė, E. (2013) · Biologija · doi:10.6001/biologija.v58i4.2601 · Cited by 1
Transforming Growth Factor-β in Lung Cancer, Carcinogenesis, and Metastasis
Jakowlew, S. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_28 · Cited by 1
Abreu, A. P., Milani, C., Katayama, M. L. H., Barbosa, K. C., da Fonseca, L. G., Góes, J. C., Brentani, M. M., & Folgueira, M. A. A. K. (2008) · The International Journal of Biological Markers · doi:10.1177/172460080802300404 · Cited by 1
Integrative Functional Analysis Improves Information Retrieval in Breast Cancer
Rodríguez, J. C., González, G. A., Fresno, C., & Fernández, E. A. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-25751-8_6 · Cited by 1
Multiple testing procedures for complex structured hypotheses and directional decisions
Grandhi, A. (2015) · Cited by 1
Role of Ceramide Kinase in Breast Cancer Progression
Payne, A. W. (2014) · Scholarly Commons (University of Pennsylvania) · Cited by 1
Breast Cancer Stem Cells: From Theory to Therapy
Conley, S. J., & Wicha, M. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_35 · Cited by 3
Context-specific gene regulatory networks subdivide intrinsic subtypes of breast cancer
Nasser, S., Cunliffe, H. E., Black, M. A., & Kim, S. (2010) · Data and Text Mining in Bioinformatics · doi:10.1145/1871871.1871875 · Cited by 1
Origins of Metastasis-Initiating Cells
Nolte, S. M., & Singh, S. K. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_11 · Cited by 1
A novel ensemble method for high-dimensional genomic data classification
Espichán-Linares, A., & Villanueva, E. (2018) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2018.8621386 · Cited by 1
Interactions et coopérations cellulaires dans le processus métastatique
Bidard, F. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
München, L.-M.-U., & Pohl, U. (2013)
Novel Degradome Markers in Breast Cancer
Pennington, C. J., Pilgrim, S. M., Span, P. N., Sweep, F. C. G. J., & Edwards, D. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5_30
Predicting breast cancer metastasis; formation of the pre-metastatic niche.
Kersten, K. (2011) · Utrecht University Repository (Utrecht University)
Les Metàstasis o la clau per vèncer el càncer
Gomis, R. R. (2013) · Estudis Romànics (Institut d'Estudis Catalans) · doi:10.2436/tscb.v0i0.77046
Kreike, B. (2011) · UvA-DARE (University of Amsterdam)
Self-citationBayesian analysis of oncogenic pathway activation
Bryant, A. I. (2011) · Otago University Research Archive (University of Otago)
Brennecke, P. (2011) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006838452
Dittmar, T., Nagler, C., Schwitalla, S., Krause, K., Seidel, J., Reith, G., Niggemann, B., & Zänker, K. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-3040-5_15
Ujula, T., Salomäki, S., Autio, A. K., Luoto, P., Tolvanen, T., Lehikoinen, P., Viljanen, T., Sipilä, H. T., Härkönen, P. L., & Roivainen, A. (2010)
The roles of angiopoietin-like 4 in cancer metastasis
Teo, Z. Q. (2016) · doi:10.32657/10356/66432
Elucidating the role of E2F2 loss in mediating human breast cancer metastasis
Yuwanita, I. (2015) · Michigan State University Libraries · doi:10.25335/m5w99n
The role of angiopoietin-like 4 in skin wound repair.
Goh, Y. Y. (2011) · doi:10.32657/10356/46276
Role of angiopoietin-like 4 in tumor growth.
Zhu, P. (2011) · doi:10.32657/10356/46431
Methodological considerations for surveillance in GI practice
Holme, Ø., & Løberg, M. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.10.011
EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer
Pan, Y.-Y., Pan, J., Han, X., & Wang, W. (2018) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.231471
Singh, A. S., Gupta, A. K., Saha, S., Bhuyan, K., & Gowami, B. C. (2020) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2020/141
Interleukin 4 controls the role of macrophages in pulmonary metastatic tumor cell seeding and growthPreprint
Rodríguez-Tirado, C., Entenberg, D. R., Li, J., Qian, B., Condeelis, J. S., & Pollard, J. W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.28.474388
Ben‐Ze'ev, A. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13453957.14827055
Sethi, T., & Rooney, C. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717954412.793469193
Castration Induced Neuroendocrine Mediated Progression of Prostate Cancer
Evans, C. P. (2008) · Defense Technical Information Center (DTIC) · doi:10.21236/ada492892
Gautschi, O. P., Tepper, C. G., Purnell, P. R., Izumiya, Y., Evans, C. P., Green, T. P., Desprez, P. Y., Lara, P. N., Gandara, D. R., Mack, P. C., et al. (2023) · doi:10.1158/0008-5472.c.6497480
Driouch, K., Bonin, F., Sin, S., Cizeron-Clairac, G., & Lidereau, R. (2023) · doi:10.1158/0008-5472.c.6500546
Culhane, A. C., & Quackenbush, J. F. (2023) · doi:10.1158/0008-5472.22377866
Fig.S1 to S7 from CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Turcotte, M., Allard, D., Mittal, D., Barèche, Y., Buisseret, L., José, V., Pommey, S., Delisle, V., Loi, S., Joensuu, H., et al. (2023) · doi:10.1158/0008-5472.22415396
Pettersson, F., Yau, C. S. F., Dobocan, M. C., Čuljković, B., Retrouvay, H., Puckett, R., Flores, L. M., Krop, I. E., Rousseau, C., Cocolakis, E., et al. (2023) · doi:10.1158/1078-0432.22443033
Azim, H. A., Michiels, S., Bedard, P. L., Singhal, S. K., Criscitiello, C., Ignatiadis, M., Haibe‐Kains, B., Piccart, M. J., Sotiriou, C. P., & Loi, S. (2023) · doi:10.1158/1078-0432.22443108
Azim, H. A., Michiels, S., Bedard, P. L., Singhal, S. K., Criscitiello, C., Ignatiadis, M., Haibe‐Kains, B., Piccart, M. J., Sotiriou, C. P., & Loi, S. (2023) · doi:10.1158/1078-0432.22443129
Culhane, A. C., & Quackenbush, J. F. (2023) · doi:10.1158/0008-5472.22377866.v1
Supplementary Methods from Relationships between LDH-A, Lactate, and Metastases in 4T1 Breast Tumors
Rizwan, A., Serganova, I. S., Khanin, R., Karabeber, H., Ni, X., Thakur, S. B., Zakian, K. L., Blasberg, R. G., & Koutcher, J. A. (2023) · doi:10.1158/1078-0432.22450928.v1
Data from Activation of Notch Signaling in a Xenograft Model of Brain Metastasis
Nam, D., Jeon, H.-M., Kim, S., Kim, M., Lee, Y.-J., Lee, M. S., Kim, H., Joo, K. M., Lee, D. S., Price, J. E., et al. (2023) · doi:10.1158/1078-0432.c.6517138
Data from Activation of Notch Signaling in a Xenograft Model of Brain Metastasis
Nam, D., Jeon, H.-M., Kim, S., Kim, M., Lee, Y.-J., Lee, M. S., Kim, H., Joo, K. M., Lee, D. S., Price, J. E., et al. (2023) · doi:10.1158/1078-0432.c.6517138.v1
Charafe‐Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M. E., Esterni, B., Houvenaeghel, G. F., Extra, J.-M., Bertucci, F., Jacquemier, J. D., et al. (2023) · doi:10.1158/1078-0432.c.6518103.v1
Charafe‐Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M. E., Esterni, B., Houvenaeghel, G. F., Extra, J.-M., Bertucci, F., Jacquemier, J. D., et al. (2023) · doi:10.1158/1078-0432.c.6518103
Verma, N., Müller, A., Kothari, C., Panayotopoulou, E. G., Kedan, A., Selitrennik, M., Mills, G. B., Nguyen, L. K., Shin, S., Karn, T., et al. (2023) · doi:10.1158/0008-5472.22412934
Verma, N., Müller, A., Kothari, C., Panayotopoulou, E. G., Kedan, A., Selitrennik, M., Mills, G. B., Nguyen, L. K., Shin, S., Karn, T., et al. (2023) · doi:10.1158/0008-5472.22412934.v1
Fig.S1 to S7 from CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Turcotte, M., Allard, D., Mittal, D., Barèche, Y., Buisseret, L., José, V., Pommey, S., Delisle, V., Loi, S., Joensuu, H., et al. (2023) · doi:10.1158/0008-5472.22415396.v1
Pettersson, F., Yau, C. S. F., Dobocan, M. C., Čuljković, B., Retrouvay, H., Puckett, R., Flores, L. M., Krop, I. E., Rousseau, C., Cocolakis, E., et al. (2023) · doi:10.1158/1078-0432.22443033.v1
Azim, H. A., Michiels, S., Bedard, P. L., Singhal, S. K., Criscitiello, C., Ignatiadis, M., Haibe‐Kains, B., Piccart, M. J., Sotiriou, C. P., & Loi, S. (2023) · doi:10.1158/1078-0432.22443129.v1
Supplementary Methods from Relationships between LDH-A, Lactate, and Metastases in 4T1 Breast Tumors
Rizwan, A., Serganova, I. S., Khanin, R., Karabeber, H., Ni, X., Thakur, S. B., Zakian, K. L., Blasberg, R. G., & Koutcher, J. A. (2023) · doi:10.1158/1078-0432.22450928
Supplementary Methods from SPSB1 Promotes Breast Cancer Recurrence by Potentiating c-MET Signaling
Feng, Y., Pan, T.-C., Pant, D. K., Chakrabarti, K. R., Alvarez, J. V., Ruth, J. R., & Chodosh, L. A. (2023) · doi:10.1158/2159-8290.22530749.v1
Rajan, N., Primac, I., Etlioglu, H. E., Debruyne, L., Janssen, A., Sallam, M., Tabury, K., Quintens, R., Tjalma, W. A. A., & Benotmane, M. A. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70101
The CXCL10/CXCR3 axis is essential for sustaining immunological dormancy in breast cancerPreprint
Yilmaz, A., Haerri, L., Granda, M. E., Coquoz, O., Lan, Q., & Rüegg, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.26.678769
Targeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer
Sim, L. C.-L., Kuo, Y.-Z., Cheng, T.-C., Chen, C.-H., Hsiao, J., Ooi, M.-X., Yun, Z., Kao, H., Tsai, S., & Wu, L. (2025) · BMC Cancer · doi:10.1186/s12885-025-15020-z
Garcia-Santillan, A. D., Lichtenberg, J. Y., Shen, H., Rodriguez, J. M., Makar, S., Barra, J., Clark, N. M., Du, W., Martinez, L. M., Hadjis, A. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.25.684515
Self-citationEpigenetic programs shaping lung metastasis in triple-negative breast cancerPreprint
Marzese, D. M., Bedoya-López, A. F., Orozco, J. I. J., Ensenyat-Méndez, M., Valdez, B., Íñiguez-Muñoz, S., Boiko, A., Xie, H., DiNome, M. L., & Llinàs‐Arias, P. (2025) · Research Square · doi:10.21203/rs.3.rs-7659153/v1
Tanabe, A., Ndzinu, J., & Sahara, H. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.101046
Additional file 10 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737017
Additional file 7 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737041
Additional file 6 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737038
Additional file 1 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737023
Additional file 5 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737035
Additional file 8 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737044
Additional file 4 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737032
Additional file 3 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737029
Wang, H., Wang, X., & Xu, L. (2024) · Figshare · doi:10.6084/m9.figshare.25036221
Additional file 11 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737020
Cai, R., Wang, P., Zhao, X., Lu, X., Deng, R., Wang, X., Su, Z., Hong, C., & Lin, J. (2020) · Figshare · doi:10.6084/m9.figshare.12038061
Additional file 9 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737047
Additional file 2 of Cellular dormancy in minimal residual disease following targeted therapy
Ruth, J. R., Pant, D. K., Pan, T.-C., Seidel, H. E., Baksh, S. C., Keister, B. A., Singh, R., Sterner, C. J., Bakewell, S. J., Moody, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14737026
Robust Association of Breast Cancer Co-morbidity Using Subtype-specific Expressed Genes
Gupta, M., Verma, S., Rao, S., & Kumar, R. (2026) · Current Drug Targets · doi:10.2174/0113894501450605260121095416
Bastid, J. (2009) · theses.fr (ABES) · doi:10.70675/1f08a215z4b9cz4886z8897z7926d12b1bff
Gharabaghi, M. A., & Gholamzadeh, M. (2026) · BMC Pulmonary Medicine · doi:10.1186/s12890-026-04530-6
Genes that mediate breast cancer metastasis to the brain
Bos, P., Zhang, X., Nadal, C., Shu, W., Gomis, R., Nguyen, D., Minn, A. J., van de Vijver, M. J., Wl, G., Foekens, J., et al. (2009) · EUR Research Repository (Erasmus University Rotterdam)
Self-citationMa, C., Ma, C., Xing, X., Sun, C., Guan, L., Schiöth, H. B., & Liu, W. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0053
Integrating the molecular subtypes of breast cancer into a novel prognostic model
Haibe‐Kains, B., Desmedt, C., Rothé, F., Piccart, M. J., Bontempi, G., & Sotiriou, C. P. (2009) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
Sampson, E. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26027
Metadata
- Authors
- Minn, A. J., Gupta, G. P., Padua, D., Bos, P., Nguyen, D. X., Nuyten, D., Kreike, B., Zhang, Y., Wang, Y., Ishwaran, H., Foekens, J. A., van de Vijver, M., & Massagué, J.
- Affiliations
- University of Chicago (US)
- Memorial Sloan Kettering Cancer Center (US)
- The Netherlands Cancer Institute (NL)
- Johnson & Johnson (United States) (US)
- Cleveland Clinic (US)
- Erasmus MC (NL)
- **Department of Diagnostic Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-04-17
- Volume
- 104
- Issue
- 16
- Pages
- 6740-6745
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1871856
- OpenAlex
- W2021880490
- Cited by
- 400
- References
- 27
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 3 · 2023: 25 · 2022: 10 · 2021: 32 · 2020: 16 · 2019: 12 · 2018: 19 · 2017: 16 · 2016: 22 · 2015: 22 · 2014: 29 · 2013: 24 · 2012: 28
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- U.S. Public Health Service (P01-94060)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, lung metastasis, tumor size, primary tumor growth, intravasation, prognostic gene signature, distant recurrence, overall survival, tumor microenvironment
- MeSH terms
- Animals, Breast Neoplasms, Female, Humans, Lung Neoplasms, Mammary Neoplasms, Experimental, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review